Lipoma versus well-differentiated liposarcoma

USG · CT · MRI

First and second year — the floor first, then every step

Ultrasound can suggest a fatty mass by echogenicity and compressibility; it cannot prove fat and cannot exclude liposarcoma.

Orient first

  • A lipoma is typically compressible, isoechoic or mildly hyperechoic to subcutaneous fat, and avascular. None of those features proves fat.
  • Thick internal septa, nodular hypoechoic foci and internal Doppler flow are the sonographic warnings — they are reasons to stop calling it a simple lipoma, not a diagnosis of sarcoma.
  • Ultrasound cannot measure Hounsfield units and cannot run fat saturation, so the honest next sentence is the name of the confirming study.

Acquire the study

  • High-frequency LINEAR probe; compare with adjacent subcutaneous fat at the SAME depth and gain.
  • Colour Doppler with low-flow settings before concluding the mass is avascular.
  • State whether the mass is subcutaneous or intramuscular — that single word decides MRI versus leave-alone.

The manoeuvre

  • Measure in three planes and state the compartment: subcutaneous versus intramuscular.
  • Compare echogenicity with adjacent fat at the same depth; note compressibility under the probe.
  • Look for thick septa, nodular non-fatty foci and internal colour Doppler flow.
  • If any of those are present, or if the mass is deep, name MRI as the next study rather than concluding lipoma.

What confirms it

  • A well-circumscribed, purely fatty mass with only thin septa and no enhancement of nodules is a lipoma.
  • Thick septa, nodular non-fatty foci or enhancement within the fat make well-differentiated liposarcoma the leading concern and need MRI if not already done, then histology.

What licenses you to exclude it

  • ⚠️ ULTRASOUND AND CT OFTEN CANNOT EXCLUDE an atypical lipomatous tumour. Homogeneous fat on CT is not a licence to stop. MRI is the characterisation study; MDM2 amplification on histology is the discriminator imaging does not have.
  • A superficial, small, purely fatty subcutaneous mass with thin septa and no nodules can be called a lipoma. Anything deep, large, or internally complex cannot.

The classic misread

  • Calling an echogenic neck lump a lipoma on ultrasound alone.
  • Not saying whether the mass is subcutaneous or intramuscular.

Reference values

Each value carries the caveat that keeps it from being misused. Normal limits and diagnostic criteria are kept apart on purpose: a disease cut-off read as a normal range is the more dangerous mistake.

Diagnostic criteria

  • Fat-containing lesions · Attenuation of macroscopic fatat or below −10 HU

    Macroscopic fat in a renal mass makes angiomyolipoma the leading diagnosis (in the absence of calcification), and supports adrenal myelolipoma or ovarian dermoid in those organs — but fat-poor AML exists, so absence of fat excludes nothing.

    CT

See it on real cases

Direct links to Radiopaedia — the reference article and worked cases with their images. Each opens on Radiopaedia.

Key papers

Reviews and guidelines from RSNA, ESR and related journals. Each opens at its DOI.

  1. Diagnostic accuracy of CT and MR features for detecting atypical lipomatous tumors and malignant liposarcomas: a systematic review and meta-analysis ↗Wilson MP, Haidey J, Murad MH, et al. · European Radiology 2023ESR · PubMed
  2. Diagnostic work-up of lipomatous tumors: a decision-making analysis among European sarcoma centers ↗Naimi A, Putora PM, Rothermundt C, et al. · Insights into Imaging 2025ESR · PubMed
  3. The management of deep-seated, lowgrade lipomatous lesions ↗Al-Ani Z, Fernando M, Wilkinson V, et al. · British Journal of Radiology 2018BIR · PubMed
  4. The histological variants of liposarcoma: predictive MRI findings with prognostic implications, management, follow-up, and differential diagnosis ↗Rizer M, Singer AD, Edgar M, et al. · Skeletal Radiology 2016ISS · PubMed

More searches

More in Musculoskeletal